Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
Gaceta Sanitaria|April 19, 2008
[Discrete-event simulation models in the economic evaluation of health technologies and health products]José Manuel Rodríguez Barrios, David Serrano, Toni Monleón, et al.
Pharmacoeconomics|February 8, 2014
Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literatureKevin Marsh, Tereza Lanitis, David Neasham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
The Use of MCDA in HTA: Great Potential, but More Effort NeededKevin D Marsh, Mark Sculpher, J Jaime Caro, et al.
Cost Effectiveness and Resource Allocation : C/E|April 17, 2004
Health and economic impact of combining metformin with nateglinide to achieve glycemic control: Comparison of the lifetime costs of complications in the U.KAlexandra J Ward, Maribel Salas, J Jaime Caro, et al.
BMC Cardiovascular Disorders|June 24, 2005
The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large databaseJaime Caro, Kristen Migliaccio-Walle, Khajak J Ishak, et al.
Pharmacoeconomics|July 31, 2009
Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysisElise M Pelletier, Boyung Shim, Rami Ben-Joseph, et al.
Hemoglobin|November 19, 2014
Erythropoietin levels in patients with sickle cell disease do not correlate with known inducers of erythropoietinE Dianne Pulte, Steven E McKenzie, Jaime Caro, et al.
International Journal of Technology Assessment in Health Care|December 27, 2017
PATIENT-CENTERED DECISION MAKING: LESSONS FROM MULTI-CRITERIA DECISION ANALYSIS FOR QUANTIFYING PATIENT PREFERENCESKevin Marsh, J Jaime Caro, Erica Zaiser, et al.
Pageof 16